Brief: China Grand Pharma And Healthcare Sees HY Consol Net Profit Attributable To Increase Of Not Less Than 50%
27/07/2021 12:27
July 27 (Reuters) - China Grand Pharmaceutical and
Healthcare Holdings Ltd 0512.HK :
* SEES CONSOLIDATED NET PROFIT ATTRIBUTABLE TO INCREASE OF
NOT
LESS THAN 50% FOR HY
* EXPECTED RESULT DUE TO FAIR VALUE CHANGE OF INVESTMENT
PORTFOLIO
CONTRIBUTES INCREMENT OF INVESTMENT INCOME
Source text for Eikon: ID:nHKS7FSMKc
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement